Načítá se...
Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
Background: Hereditary angioedema (HAE) is a rare C1-inhibitor (C1-INH) deficiency disease involving recurrent painful episodes of severe swelling that should be promptly treated. Aims: To determine cost and utility estimates for on-demand treatment of HAE attacks in order to better clarify and cont...
Uloženo v:
| Vydáno v: | J Drug Assess |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764406/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658300 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|